Fei Yu
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 28
- SARS-CoV-2 and COVID-19 Research 13
- Viral gastroenteritis research and epidemiology 8
- HIV/AIDS Research and Interventions 8
- Virology top 2%
- HIV Research and Treatment 34
- Animal Science and Zoology top 2%
- Epidemiology top 5%
- Influenza Virus Research Studies 15
- Respiratory viral infections research 8
- Hepatology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 9
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fei Yu
75 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 1.7k
- Virology 402
- Animal Science and Zoology 264
- Epidemiology 862
- Hepatology 150
Countries citing papers authored by Fei Yu
This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).
Fields of papers citing papers by Fei Yu
This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 57 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 77 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 270 | |
| 11 | 2017 | 118 | |
| 12 | 2016 | 23 | |
| 13 | 2015 | 14 | |
| 14 | 2015 | 14 | |
| 15 | 2015 | 28 | |
| 16 | 2014 | 24 | |
| 17 | 2014 | 16 | |
| 18 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorbreakdown → | 2014 | 317 |
| 19 | 2013 | 88 | |
| 20 | Characteristics of inferior variation of water environment in Hutuohe River dried-up area | 2001 | 2 |
About Fei Yu
Fei Yu is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 83 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (34 papers), HIV/AIDS drug development and treatment (28 papers), Influenza Virus Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Viral gastroenteritis research and epidemiology (8 papers), Respiratory viral infections research (8 papers) and HIV/AIDS Research and Interventions (8 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (402 citations) and Animal Science and Zoology (264 citations). Fei Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shibo Jiang, Lanying Du, Lu Lu, Ruiying Liang, Chungen Pan, David M. Ojcius, Xiaoqian Deng, Lili Wang, Meng Su and Naru Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.